6‐Aryl and Heterocycle Quinazoline Derivatives as Potent EGFR Inhibitors with Improved Activity toward Gefitinib‐Sensitive and ‐Resistant Tumor Cell Lines

  • Mostafa M. Hamed, Dalal A. Abou El Ella, Adam B. Keeton, Gary A. Piazza, Ashraf H. Abadi, Rolf W. Hartmann, Matthias Engel
  • ChemMedChem, July 2013, Wiley
  • DOI: 10.1002/cmdc.201300147

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1002/cmdc.201300147

The following have contributed to this page: Professor Ashraf H. Abadi